Article Information
History
- March 24, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Jesus de la Fuente1,2,
- Sara Llorente-González3,4,5,
- Patricia Fernandez-Robredo3,4,5,
- María Hernandez3,4,5,
- Alfredo García-Layana3,4,5,
- Idoia Ochoa1,6,*,†,
- Sergio Recalde3,4,5,*,†,
- Spanish AMD group
- 1Department of Electrical and Electronics Engineering, School of Engineering (Tecnun), University of Navarra, Spain
- 2Center for Data Science, New York University, New York
- 3Retinal Pathologies and New Therapies Group, Experimental Ophtalmology Laboratory, Department of Ophtalmology, Clinica Universidad de Navarra, Pamplona, Spain
- 4Navarra Institute for Health Research, IdiSNA, Pamplona, Spain
- 5Thematic Network of Cooperative Health Research in Eye Diseases (Oftared), Health Institute Carlos III (ISCIII), Department of Ophtalmology, Clinica Universidad de Navarra, Pamplona, Spain
- 6Institute for Data Science and Artificial Intelligence (DATAI), University of Navarra, Spain
- ↵†Corresponding authors. Correspondence: srecalde{at}unav.es & iochoal{at}unav.es
↵* These authors contributed equally to this work.
Posted March 24, 2023.
Suitability of Machine Learning for Atrophy and Fibrosis Development in Neovascular Age-Related Macular Degeneration
